Merja Haikola
Comptroller/Controller/Auditor at BBS-BIOACTIVE BONE SUBSTITUTES OYJ
Profile
Merja Haikola is currently the Accountable Director at BBS-Bioactive Bone Substitutes Plc since 2023.
Previously, she worked as a Principal at AKELA Pharma Oy from 1988 to 2003, at Leiras Oy as a Principal, and at Cancer Targeting Technologies Oy as a Principal from 2003 to 2006.
Merja Haikola active positions
Companies | Position | Start |
---|---|---|
BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Comptroller/Controller/Auditor | 2023-12-22 |
Former positions of Merja Haikola
Companies | Position | End |
---|---|---|
Cancer Targeting Technologies Oy
Cancer Targeting Technologies Oy Pharmaceuticals: MajorHealth Technology Cancer Targeting Technologies Oy used to develop anticancer drugs and drug delivery systems based on cancer specific peptides and peptide liposomes. It was also developed diagnostic tools. The company was located in Helsinki, Finland | Corporate Officer/Principal | 2005-12-31 |
AKELA Pharma Oy
AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Corporate Officer/Principal | 2002-12-31 |
Leiras Oy
Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Health Technology |
Private companies | 3 |
---|---|
AKELA Pharma Oy
AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Health Technology |
Leiras Oy
Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Health Technology |
Cancer Targeting Technologies Oy
Cancer Targeting Technologies Oy Pharmaceuticals: MajorHealth Technology Cancer Targeting Technologies Oy used to develop anticancer drugs and drug delivery systems based on cancer specific peptides and peptide liposomes. It was also developed diagnostic tools. The company was located in Helsinki, Finland | Health Technology |
- Stock Market
- Insiders
- Merja Haikola